What Is Gabapentin? Drug Class, Schedule & Drug Test Answers
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026
Quick answer: Gabapentin is a Anticonvulsant/gabapentinoid. Unscheduled federally; Schedule V in a few states. Here's how the drug is classified, whether it's a narcotic/controlled substance, and what that means for testing.
What is Gabapentin?
Drug class: Anticonvulsant/gabapentinoid
Federal schedule: Unscheduled federally; Schedule V in a few states.
Gabapentin isn't on standard employment panels. Pain clinics, MAT programs, and some probation systems monitor it specifically because of abuse-potential findings — those orders use dedicated assays.
Is Gabapentin a narcotic?
It is not classified as a narcotic under the DEA's federal schedule. What matters more for you: Unscheduled federally; Schedule V in a few states..
Does it show up on drug tests?
No — it is not on the standard 5-panel; it appears only on expanded or panel-specific orders. See the full Gabapentin drug test guide for detection windows and cutoffs.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Does Gabapentin Show up on a Drug Test?
No — Gabapentin is absent from standard drug panels. Full guide →
Can Gabapentin Cause a False Positive Drug Test?
Can Gabapentin trigger a false positive? Cross-reactivity evidence, confirmation testing, and how to clear your name with the MRO. Full guide →
How Long Does Gabapentin Show up on a Drug Test?
How long Gabapentin stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
Gabapentin Drug Test Guide: Panels, Detection Windows & More?
Complete Gabapentin drug test guide: which panels detect it, urine/hair/saliva/blood detection windows, cutoff levels and prescription verification. Full guide →
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)